【my arborvitae is turning brown】Is Ador Welding Limited’s (NSE:ADORWELD) Balance Sheet A Threat To Its Future?
Ador Welding Limited (
NSE:ADORWELD
) is my arborvitae is turning browna small-cap stock with a market capitalization of ₹4.2b. While investors primarily focus on the growth potential and competitive landscape of the small-cap companies, they end up ignoring a key aspect, which could be the biggest threat to its existence: its financial health. Why is it important? Evaluating financial health as part of your investment thesis is essential, since poor capital management may bring about bankruptcies, which occur at a higher rate for small-caps. I believe these basic checks tell most of the story you need to know. However, since I only look at basic financial figures, I recommend you
dig deeper yourself into ADORWELD here
.
Does ADORWELD produce enough cash relative to debt?
ADORWELD has built up its total debt levels in the last twelve months, from ₹356m to ₹813m made up of predominantly near term debt. With this growth in debt, ADORWELD’s cash and short-term investments stands at ₹199m , ready to deploy into the business. Moving onto cash from operations, its operating cash flow is not yet significant enough to calculate a meaningful cash-to-debt ratio, indicating that operational efficiency is something we’d need to take a look at. For this article’s sake, I won’t be looking at this today, but you can examine some of ADORWELD’s
operating efficiency ratios such as ROA here
.
Does ADORWELD’s liquid assets cover its short-term commitments?
At the current liabilities level of ₹1.7b, it seems that the business has been able to meet these commitments with a current assets level of ₹2.9b, leading to a 1.7x current account ratio. Generally, for Machinery companies, this is a reasonable ratio since there’s a sufficient cash cushion without leaving too much capital idle or in low-earning investments.
NSEI:ADORWELD Historical Debt, March 1st 2019
Is ADORWELD’s debt level acceptable?
With a debt-to-equity ratio of 33%, ADORWELD’s debt level may be seen as prudent. This range is considered safe as ADORWELD is not taking on too much debt obligation, which can be restrictive and risky for equity-holders.
Next Steps:
ADORWELD’s debt level is appropriate for a company its size, and it is also able to generate sufficient cash flow coverage, meaning it has been able to put its debt in good use. Furthermore, the company exhibits an ability to meet its near term obligations should an adverse event occur. Keep in mind I haven’t considered other factors such as how ADORWELD has been performing in the past. I recommend you continue to research Ador Welding to get a more holistic view of the stock by looking at:
Story continues
Historical Performance
: What has ADORWELD’s returns been like over the past? Go into more detail in the past track record analysis and take a look at
the free visual representations of our analysis
for more clarity.
Other High-Performing Stocks
: Are there other stocks that provide better prospects with proven track records? Explore our
free list of these great stocks here
.
We aim to bring you long-term focused research analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.
If you spot an error that warrants correction, please contact the editor at
. This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Simply Wall St has no position in the stocks mentioned. Thank you for reading.
View comments
(责任编辑:Fashion)
- ·HSBC, Standard Chartered Shares Plunge After Dividend Payment Cancellations
- ·South African drugmaker Aspen sees no immediate impact of India's decision to curb drug exports
- ·Managers’ transactions - 1
- ·Blockchain Industries Appoints New Board Members
- ·United Kingdom Cardiac Rhythm Management Devices Market Outlook to 2025 - Cardiac Resynchronisation Therapy (CRT), Implantable Cardioverter Defibrillators (ICD), Implantable Loop Recorders (ILR) and Pacemakers
- ·FITB ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of June 8, 2020 in the Class Action Filed on Behalf of Fifth Third Bancorp Limited Shareholders
- ·SHAREHOLDER ACTION NOTICE: The Schall Law Firm Announces it is Investigating Claims Against Canaan Inc. and Encourages Investors with Losses to Contact the Firm
- ·Spa chain secured $5.6M in coronavirus relief for small businesses despite losses last year
- ·United Kingdom Cardiac Rhythm Management Devices Market Outlook to 2025 - Cardiac Resynchronisation Therapy (CRT), Implantable Cardioverter Defibrillators (ICD), Implantable Loop Recorders (ILR) and Pacemakers
- ·Tembo Gold Adds 70 km2 Adjoining Bulyanhulu and Provides Prospecting Licence Update
- ·CanWel Building Materials Group (TSE:CWX) Shareholders Have Felt Some Pain With A 19% Loss On Their Investment
- ·Is Burlington Stores (BURL) a Solid Growth Stock? 3 Reasons to Think Yes
- ·Fed virus-driven cut may test new approach to inflation
- ·iRhythm Technologies, Inc. Just Reported Full-Year Earnings: Have Analysts Changed Their Mind On The Stock?
- ·Energy Fuels Inc.'s (TSE:EFR) Intrinsic Value Is Potentially 96% Above Its Share Price
- ·Gold ETFs Attain Record YTD Inflows Amid Global Uncertainties
- ·Freedom Trail and Black Heritage Trail Bring History Into Homes Near and Far
- ·Dollar Up Despite Vaccine Approval and Possibility of U.S. Stimulus Measures
- ·CRISPR/Cas9 Gene-Editing Therapy CTX001™ for Severe Hemoglobinopathies Accepted for Plenary Presentation at the 62nd American Society of Hematology (ASH) Meeting and Exposition
- ·Clarivate Analytics Plc (CCC) Q1 Earnings and Revenues Miss Estimates